A critical advance in cancer study is emerging with the use of mini-antibodies to re-engage damaged p53. This vital malignant protector protein is frequently lost in various types of tumors, resulting uncontrolled https://linkingbookmark.com/story21836901/mini-antibodies-restore-tumor-suppressor-p53-a-potential-pathway-for-tumor-therapy